ASH 2022 Conference Coverage
Playback speed
10 seconds
ASH 2022 Asciminib as Initial Therapy for Patients With CML-CP: H. Jean Khoury Cure CML Consortium Study
By
ASH 2022 Conference Coverage
FEATURING
Ehab Atallah
By
ASH 2022 Conference Coverage
FEATURING
Ehab Atallah
86 views
December 21, 2022
Login to view comments.
Click here to Login
Leukemia